ArticleRespiratory research2026
A novel quantitative method for CT assessment of bronchiectasis using AI-based airway segmentation and upper limits of normal airway caliber.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBronchiectasis represents a growing global health burden. While computed tomography (CT) is essential for diagnosis, current criteria rely on broncho-arterial ratios and visual assessments, which are subject to inter-observer variability and can be confounded by pathological changes in arterial caliber. This study aimed to develop a novel quantitative method for assessing bronchiectasis by incorporating artificial intelligence-based airway segmentation and establishing location-specific upper limits of normal (ULN) for airway dimensions derived from healthy controls.
methodsWe analyzed chest CT scans from 459 healthy non-smokers who participated in a lung cancer screening program. Of these, 445 were used to calculate sex- and height-specific ULN values, while 14 served as independent controls for comparison with 14 patients clinically diagnosed with bronchiectasis. Following automatic segmentation of airway trees using previously-established artificial intelligence-based quantitative CT image analysis software, we extracted centerlines. At each point along the airway centerline, we measured the cross-sectional radius and the distance from the lobar bronchus origin. The ULN for airway radius was defined as the 95th percentile of measurements from healthy controls, stratified by sex and height. In patients with bronchiectasis, airways exceeding the ULN were classified as bronchiectatic, and bronchiectatic airway volume percentage (BEV%) was calculated.
resultsMale sex and height, but not age, were significantly associated with lobar bronchus radius. Location-specific ULN values were established for all five lobes as a function of distance from lobar origins, stratified by sex and height. BEV% was significantly higher in patients with bronchiectasis compared to matched controls (p < 0.001) and strongly correlated with the Reiff score (rho = 0.722, p = 0.004).
conclusionThis study established a novel reproducible approach for quantifying bronchiectasis using AI-based airway segmentation and location-specific normative airway dimensions without relying on broncho-arterial ratios. This method potentially enhances diagnostic accuracy and disease monitoring in the management of bronchiectasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.